Watchlist Price Alert

Neoleukin Therapeutics In... (NLTX)

NASDAQ: NLTX · Real-Time Price · USD

3.49

0.05 (1.45%)

At close: Dec 18, 2023, 9:00 PM

Neoleukin Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	37.89M	142.47M	192.56M	143.09M	76.93M	52.03M	32.3M
Short-Term Investments	58.5M	n/a	n/a	n/a	n/a	56.05M	70.76M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	50.05M
Other Long-Term Assets	936K	1.93M	1.93M	30K	53K	599K	n/a
Receivables	n/a	n/a	n/a	503K	237K	740K	426K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.75M	1.52M	1.97M	n/a	n/a	n/a	n/a
Total Current Assets	99.13M	143.99M	194.52M	143.6M	77.17M	108.83M	103.48M
Property-Plant & Equipment	15.88M	17.22M	13.72M	2.83M	400K	905K	849K
Goodwill & Intangibles	n/a	128K	347K	567K	n/a	n/a	n/a
Total Long-Term Assets	16.81M	19.27M	16M	3.43M	453K	1.5M	50.9M
Total Assets	115.95M	163.26M	210.52M	147.02M	77.62M	110.33M	154.38M
Account Payables	478K	526K	1.32M	1.6M	702K	6.02M	6.86M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.51M	1.22M	708K	618K	n/a	n/a	n/a
Other Current Liabilities	9.07M	6.89M	5.86M	2.52M	3.92M	4.94M	2.66M
Total Current Liabilities	11.06M	8.64M	7.89M	4.74M	4.63M	10.96M	9.52M
Long-Term Debt	10.55M	11.76M	11.41M	593K	6K	33K	47K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	313K	453K	150K
Total Long-Term Liabilities	10.55M	11.76M	11.41M	593K	319K	486K	197K
Total Liabilities	21.62M	20.4M	19.3M	5.34M	4.95M	11.44M	9.72M
Total Debt	12.07M	12.98M	12.12M	1.21M	6K	33K	47K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-451.06M	-393.5M	-332.81M	-299.53M	-230.09M	-198.5M	-148.28M
Comprehensive Income	-21K	n/a	n/a	n/a	-443K	-70K	-169K
Shareholders Equity	94.33M	142.86M	191.22M	141.69M	72.67M	98.89M	144.66M
Total Investments	58.5M	n/a	n/a	n/a	n/a	56.05M	120.8M